Carnegie Capital Asset Management LLC Sells 1,661 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Carnegie Capital Asset Management LLC lowered its position in shares of UnitedHealth Group Incorporated (NYSE:UNHGet Rating) by 11.4% in the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 12,863 shares of the healthcare conglomerate’s stock after selling 1,661 shares during the quarter. Carnegie Capital Asset Management LLC’s holdings in UnitedHealth Group were worth $5,151,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds also recently made changes to their positions in the company. NorthCrest Asset Manangement LLC increased its holdings in UnitedHealth Group by 9.5% in the first quarter. NorthCrest Asset Manangement LLC now owns 518 shares of the healthcare conglomerate’s stock valued at $264,000 after purchasing an additional 45 shares during the last quarter. Cullinan Associates Inc. grew its stake in UnitedHealth Group by 2.1% in the second quarter. Cullinan Associates Inc. now owns 27,068 shares of the healthcare conglomerate’s stock valued at $13,903,000 after acquiring an additional 555 shares during the period. 626 Financial LLC grew its stake in UnitedHealth Group by 1.5% in the second quarter. 626 Financial LLC now owns 2,387 shares of the healthcare conglomerate’s stock valued at $1,224,000 after acquiring an additional 35 shares during the period. EverSource Wealth Advisors LLC grew its stake in UnitedHealth Group by 67.7% in the first quarter. EverSource Wealth Advisors LLC now owns 2,557 shares of the healthcare conglomerate’s stock valued at $1,303,000 after acquiring an additional 1,032 shares during the period. Finally, TPG Financial Advisors LLC grew its stake in UnitedHealth Group by 8.6% in the second quarter. TPG Financial Advisors LLC now owns 2,423 shares of the healthcare conglomerate’s stock valued at $1,245,000 after acquiring an additional 192 shares during the period. Institutional investors own 87.25% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of research firms have issued reports on UNH. UBS Group boosted their target price on UnitedHealth Group from $545.00 to $570.00 and gave the company a “neutral” rating in a research note on Thursday, July 21st. Deutsche Bank Aktiengesellschaft upped their price objective on UnitedHealth Group from $556.00 to $569.00 and gave the stock a “buy” rating in a research report on Thursday, September 8th. Argus upped their price objective on UnitedHealth Group from $580.00 to $650.00 and gave the stock a “buy” rating in a research report on Monday, July 25th. Morgan Stanley upped their price objective on UnitedHealth Group from $570.00 to $587.00 in a research report on Monday, July 18th. Finally, Raymond James upped their price objective on UnitedHealth Group from $620.00 to $635.00 in a research report on Thursday. Three investment analysts have rated the stock with a hold rating, fifteen have assigned a buy rating and two have assigned a strong buy rating to the company’s stock. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $586.40.

Insider Transactions at UnitedHealth Group

In other UnitedHealth Group news, CEO Andrew Witty sold 11,376 shares of the firm’s stock in a transaction on Monday, July 18th. The stock was sold at an average price of $527.90, for a total transaction of $6,005,390.40. Following the transaction, the chief executive officer now owns 76,559 shares in the company, valued at approximately $40,415,496.10. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink. In other UnitedHealth Group news, Director Stephen J. Hemsley sold 99,312 shares of the firm’s stock in a transaction on Tuesday, July 26th. The stock was sold at an average price of $534.27, for a total transaction of $53,059,422.24. Following the transaction, the director now owns 787,372 shares in the company, valued at approximately $420,669,238.44. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink. Also, CEO Andrew Witty sold 11,376 shares of the firm’s stock in a transaction on Monday, July 18th. The shares were sold at an average price of $527.90, for a total value of $6,005,390.40. Following the completion of the sale, the chief executive officer now directly owns 76,559 shares in the company, valued at approximately $40,415,496.10. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 139,051 shares of company stock worth $74,450,958. Company insiders own 0.40% of the company’s stock.

UnitedHealth Group Price Performance

NYSE:UNH opened at $517.46 on Friday. The company has a quick ratio of 0.77, a current ratio of 0.77 and a debt-to-equity ratio of 0.60. The stock’s 50 day moving average price is $530.11 and its two-hundred day moving average price is $512.45. The firm has a market capitalization of $484.02 billion, a price-to-earnings ratio of 27.02, a P/E/G ratio of 1.61 and a beta of 0.76. UnitedHealth Group Incorporated has a 12-month low of $383.12 and a 12-month high of $553.29.

UnitedHealth Group (NYSE:UNHGet Rating) last announced its earnings results on Friday, July 15th. The healthcare conglomerate reported $5.57 earnings per share for the quarter, topping analysts’ consensus estimates of $5.24 by $0.33. The company had revenue of $80.33 billion for the quarter, compared to analyst estimates of $79.68 billion. UnitedHealth Group had a return on equity of 25.45% and a net margin of 5.95%. The firm’s quarterly revenue was up 12.6% compared to the same quarter last year. During the same quarter last year, the company earned $4.70 earnings per share. On average, analysts anticipate that UnitedHealth Group Incorporated will post 21.85 earnings per share for the current year.

UnitedHealth Group Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Tuesday, September 20th. Stockholders of record on Monday, September 12th were paid a dividend of $1.65 per share. The ex-dividend date of this dividend was Friday, September 9th. This represents a $6.60 dividend on an annualized basis and a dividend yield of 1.28%. UnitedHealth Group’s dividend payout ratio (DPR) is currently 34.46%.

UnitedHealth Group Company Profile

(Get Rating)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage and well-being services to individuals age 50 and older addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; Medicaid plans, children's health insurance and health care programs; health and dental benefits; and hospital and clinical services.

Read More

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNHGet Rating).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.